Molecular Insights Consulting

Molecular Insights ConsultingMolecular Insights ConsultingMolecular Insights Consulting

Molecular Insights Consulting

Molecular Insights ConsultingMolecular Insights ConsultingMolecular Insights Consulting
  • Home
  • Recent Publications
  • SPRm
  • Contact Us
  • More
    • Home
    • Recent Publications
    • SPRm
    • Contact Us
  • Home
  • Recent Publications
  • SPRm
  • Contact Us

Discover Validate Design

Discover Validate DesignDiscover Validate DesignDiscover Validate Design

Integrating biophysics, enzymology, and structure-based drug design

Contact us

860-910-9227

Discover Validate Design

Discover Validate DesignDiscover Validate DesignDiscover Validate Design

Integrating biophysics, enzymology, and structure-based drug design

Contact us

860-910-9227

About Molecular Insights Consulting

Our Story

Molecular Insights Consulting was launched in 2024 by Dr. Felix Vajdos.  Over the course of two decades working in early-stage drug discovery in the pharmaceutical industry, Dr. Vajdos frequently saw hit identification campaigns languish (sometimes for years) with no discernible progress towards identifying bona fide leads for further development.  

Our Approach

To address this, in 2015 Dr. Vajdos assembled a multi-disciplinary group of scientists who combined  SPR, BLI, TSA, fluorescence, mechanistic enzymology, NMR, and X-ray crystallography to validate screening hits, determine their mechanisms of action, and prioritize them for further follow up.  By integrating biophysics, mechanistic enzymology, and structural biology, Dr. Vajdos brought a holistic approach to hit validation and lead optimization.  This allowed for rapid conversion of raw screening hits into high confidence leads for drug development. 

Our Mission

Now retired from the pharmaceutical industry, Dr. Vajdos's mission is to help clients find and develop the highest quality chemical matter for their drug discovery programs. By combining years of experience in biophysics, mechanistic enzymology, and structural biology, Molecular Insights Consulting is able to help guide your lead discovery efforts throughout the project's lifecycle.  


Molecular Insights Consulting is passionate about sharing their decades of experience working with biologists and chemists in big pharma to progress your preclinical candidates from inception to the clinic.

Innovative Solutions for Drug Discovery

Hit Identification

Hit Identification

Hit ID begins with a clear, focused screening strategy that is appropriate for the target.

  • Screening Strategy and Development
  • CRO Management
  • Data Analysis
  • Druggability Assessment

Hit Validation

Hit Identification

We help clients prioritize screening hits so that chemistry efforts can be focused on those with the highest likelihood of becoming leads.

  • Biophysical Characterization
  • Solubility Assessment
  • Target-Ligand Engagement
  • Mechanism of Action

Lead Optimization

Lead Optimization

Once leads have been identified, we help optimize them through structural and biophysical methods

  • Structure-Based Drug Design (X-ray, Cryo-EM)
  • Biophysical Analysis (SPR, ITC, TSA, BLI, Mass Photometry)

Copyright © 2025 Molecular Insights Consulting - All Rights Reserved.

Powered by

  • Home
  • Recent Publications
  • SPRm
  • Contact Us

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept